Association Between Human Immunodeficiency Virus (HIV) Infection and Male Hypogonadism

  • STATUS
    Recruiting
  • End date
    Nov 13, 2030
  • participants needed
    1200
  • sponsor
    National Taiwan University Hospital
Updated on 13 March 2021

Summary

Cross-sectional study investigating the prevalence of hypogonadism in HIV-infected MSM population

Description

In this study, we conduct a cross-sectional study investigating the prevalence of hypogonadism in HIV-infected MSM population. Age-matched non-HIV infected MSM group will be used as comparison group. We will also determine the risk factors associated with male hypogonadism (age, duration of HIV infection, comorbidities, BMI, ART use). Correlation will be made between serum testosterone levels and sexual function, vitality, exercise capacity, mood, and bone mineral density.

Details
Condition Hypogonadism; Ovarian, Hypogonadism; Ovarian, Hypogonadism; Ovarian, Hypogonadism; Ovarian
Treatment testosterone
Clinical Study IdentifierNCT04760574
SponsorNational Taiwan University Hospital
Last Modified on13 March 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

HIV-infected men who have sex with men
HIV non-infected men

Exclusion Criteria

Use of testosterone supplement, anabolic steroid in the past one year
History of pituitary , adrenal or gonad diseases
History of pituitary surgery or radiation therapy
History of systemic chemotherapy
Active opportunistic infection under treatment
Cancer
Severe hepatic, renal or cardiac impairment
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note